Review article · 2021 · Open access

The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas

Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Adrián Arnaiz-Leché, Sergio Roa

Cancers, 13(18), 4683 · Published 18 September 2021 · DOI 10.3390/cancers13184683

Open PDFView at the publisherCite this paper

In brief

“The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas” is a 2021 review article by Marcos Garcia-Lacarte and 4 co-authors, published in Cancers. OpenAlex counts 34 citations as of 18 November 2026, which puts it in the top 4% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at Cancers.

Citations
34
Most cited in
2026 (12)
Field-weighted impact
0.74
References
260
Authors
5

Abstract

Besides a recognized role of PD-1/PD-L1 checkpoint in anti-tumour immune evasion, there is accumulating evidence that PD-1/PD-L1 interactions between B and T cells also play an important role in normal germinal center (GC) reactions. Even when smaller in number, T follicular helper cells (TFH) and regulatory T (TFR) or B (Breg) cells are involved in positive selection of GC B cells and may result critical in the lymphoma microenvironment. Here, we discuss a role of PD-1/PD-L1 during tumour evolution in diffuse large B cell lymphoma (DLBCL), a paradigm of GC-derived lymphomagenesis. We depict a progression model, in two phases, where malignant B cells take advantage of positive selection signals derived from correct antigen-presentation and PD-1/PD-L1 inter-cellular crosstalks to survive and initiate tumour expansion. Later, a constant pressure for the accumulation of genetic/epigenetic alterations facilitates that DLBCL cells exhibit higher PD-L1 levels and capacity to secrete IL-10, resembling Breg-like features. As a result, a complex immunosuppressive microenvironment is established where DLBCL cells sustain proliferation and survival by impairing regulatory control of TFR cells and limiting IL-21-mediated anti-tumour functions of TFH cells and maximize the use of PD-1/PD-L1 signaling to escape from CD8+ cytotoxic activity. Integration of these molecular and cellular addictions into a framework may contribute to the better understanding of the lymphoma microenvironment and contribute to the rationale for novel PD-1/PD-L1-based combinational immunotherapies in DLBCL.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Garcia-Lacarte, M., Grijalba, S. C., Melchor, J., Arnaiz-Leché, A., & Roa, S. (2021). The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas. Cancers, 13(18), 4683. https://doi.org/10.3390/cancers13184683

MLA 9

Garcia-Lacarte, Marcos, et al. “The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas.” Cancers, vol. 13, no. 18, 2021, p. 4683. https://doi.org/10.3390/cancers13184683.

Chicago

Garcia-Lacarte, Marcos, Sara C. Grijalba, Javier Melchor, Adrián Arnaiz-Leché, and Sergio Roa. 2021. “The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas.” Cancers 13 (18): 4683. https://doi.org/10.3390/cancers13184683.

Harvard

Garcia-Lacarte, M. et al. (2021) ‘The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas’, Cancers, 13(18), p. 4683. doi:10.3390/cancers13184683.

IEEE

M. Garcia-Lacarte, S. C. Grijalba, J. Melchor, A. Arnaiz-Leché, and S. Roa, “The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas,” Cancers, vol. 13, no. 18, p. 4683, 2021, doi: 10.3390/cancers13184683.

BibTeX

@article{garcialacarte2021checkpoint,
  title     = {{The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas}},
  author    = {Garcia-Lacarte, Marcos and Grijalba, Sara C. and Melchor, Javier and Arnaiz-Leché, Adrián and Roa, Sergio},
  journal   = {Cancers},
  year      = {2021},
  volume    = {13},
  number    = {18},
  pages     = {4683},
  doi       = {10.3390/cancers13184683},
  url       = {https://doi.org/10.3390/cancers13184683}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202244
202366
202455
202577
20261212

Its field-weighted citation impact is 0.74: it has been cited 0.74 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment

  • PD-1/PD-L1 immune checkpoint
  • diffuse large B-cell lymphoma
  • germinal center
  • T follicular helper cells
  • regulatory T cells
  • regulatory B cells
  • IL-10
  • IL-21

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Garcia-Lacarte, M., Grijalba, S. C., Melchor, J., Arnaiz-Leché, A., & Roa, S. (2021). The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas. Cancers, 13(18), 4683. https://doi.org/10.3390/cancers13184683

How many times has this paper been cited?

34 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancers: sign in and open the PDF from this page.

Who wrote this paper?

Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Adrián Arnaiz-Leché, Sergio Roa.

What is the DOI of this paper?

10.3390/cancers13184683, permanently at https://doi.org/10.3390/cancers13184683. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.